WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.
WHO Classification
pathology
prostate carcinoma
Journal
Histopathology
ISSN: 1365-2559
Titre abrégé: Histopathology
Pays: England
ID NLM: 7704136
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
revised:
29
05
2022
received:
28
03
2022
accepted:
08
06
2022
pubmed:
28
6
2022
medline:
14
9
2022
entrez:
27
6
2022
Statut:
ppublish
Résumé
The fifth edition of the WHO Classification of Tumours of the Urinary and Male Genital Systems encompasses several updates to the classification and diagnosis of prostatic carcinoma as well as incorporating advancements in the assessment of its prognosis, including recent grading modifications. Some of the salient aspects include: (1) recognition that prostatic intraepithelial neoplasia (PIN)-like carcinoma is not synonymous with a pattern of ductal carcinoma, but better classified as a subtype of acinar adenocarcinoma; (2) a specific section on treatment-related neuroendocrine prostatic carcinoma in view of the tight correlation between androgen deprivation therapy and the development of prostatic carcinoma with neuroendocrine morphology, and the emerging data on lineage plasticity; (3) a terminology change of basal cell carcinoma to "adenoid cystic (basal cell) cell carcinoma" given the presence of an underlying MYB::NFIB gene fusion in many cases; (4) discussion of the current issues in the grading of acinar adenocarcinoma and the prognostic significance of cribriform growth patterns; and (5) more detailed coverage of intraductal carcinoma of prostate (IDC-P) reflecting our increased knowledge of this entity, while recommending the descriptive term atypical intraductal proliferation (AIP) for lesions falling short of IDC-P but containing more atypia than typically seen in high-grade prostatic intraepithelial neoplasia (HGPIN). Lesions previously regarded as cribriform patterns of HGPIN are now included in the AIP category. This review discusses these developments, summarising the existing literature, as well as the emerging morphological and molecular data that underpins the classification and prognostication of prostatic carcinoma.
Identifiants
pubmed: 35758185
doi: 10.1111/his.14711
pmc: PMC9542779
doi:
Substances chimiques
Androgen Antagonists
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
447-458Informations de copyright
© 2022 The Authors. Histopathology published by John Wiley & Sons Ltd.
Références
J Pathol. 2019 Sep;249(1):79-89
pubmed: 30993692
Am J Clin Pathol. 2002 Apr;117(4):552-7
pubmed: 11939729
Am J Surg Pathol. 2005 Sep;29(9):1228-42
pubmed: 16096414
Am J Surg Pathol. 2020 May;44(5):673-680
pubmed: 31876580
Histopathology. 2019 Sep;75(3):346-353
pubmed: 31012493
Histopathology. 2020 Nov;77(5):742-748
pubmed: 32542746
Am J Surg Pathol. 2007 May;31(5):697-705
pubmed: 17460452
Mod Pathol. 2017 Aug;30(8):1126-1132
pubmed: 28530220
Am J Surg Pathol. 2018 Dec;42(12):1693-1700
pubmed: 30138215
Am J Surg Pathol. 2014 Jun;38(6):756-67
pubmed: 24705311
Mod Pathol. 2015 Mar;28(3):457-64
pubmed: 25189638
Pathology. 2018 Jan;50(1):60-73
pubmed: 29199015
Am J Surg Pathol. 1996 Jul;20(7):802-14
pubmed: 8669528
Histopathology. 2014 Aug;65(2):216-27
pubmed: 24467262
Prostate. 2018 Jul;78(10):697-706
pubmed: 29603326
Histopathology. 2021 Jan;78(2):327-333
pubmed: 32740981
Urol Oncol. 2017 Dec;35(12):673.e9-673.e14
pubmed: 28919182
Am J Surg Pathol. 2011 Jan;35(1):92-9
pubmed: 21164292
Eur Urol Focus. 2019 May;5(3):433-442
pubmed: 29229583
Endocr Pathol. 2016 Jun;27(2):123-35
pubmed: 26885643
Am J Surg Pathol. 2015 Oct;39(10):1383-9
pubmed: 26076065
Histopathology. 2020 Sep;77(3):503-507
pubmed: 32358793
J Urol. 2019 Oct;202(4):710-716
pubmed: 31059665
Am J Surg Pathol. 2020 Aug;44(8):e87-e99
pubmed: 32459716
Biochim Biophys Acta. 2014 Dec;1846(2):630-7
pubmed: 25450825
Mol Cancer Res. 2019 Feb;17(2):446-456
pubmed: 30333152
J Clin Oncol. 2018 Aug 20;36(24):2492-2503
pubmed: 29985747
BMC Cancer. 2018 Jan 2;18(1):8
pubmed: 29295717
Mod Pathol. 2006 Jul;19(7):899-906
pubmed: 16607376
Eur J Cancer. 2019 Nov;121:7-18
pubmed: 31525487
J Urol. 2016 Oct;196(4):1076-81
pubmed: 27265220
Hum Pathol. 2017 Nov;69:1-7
pubmed: 28457729
Hum Pathol. 2014 Aug;45(8):1572-81
pubmed: 24842280
Mod Pathol. 2016 Feb;29(2):166-73
pubmed: 26743470
Mod Pathol. 2019 Nov;32(11):1666-1674
pubmed: 31189999
Histopathology. 2019 Jun;74(7):1081-1087
pubmed: 30720899
Mod Pathol. 2006 Dec;19(12):1528-35
pubmed: 16980940
Virchows Arch. 2013 Apr;462(4):429-36
pubmed: 23443941
Am J Surg Pathol. 1999 Dec;23(12):1471-9
pubmed: 10584700
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Am J Clin Pathol. 2011 Jul;136(1):98-107
pubmed: 21685037
Eur Urol. 2021 Jan;79(1):3-5
pubmed: 33189461
Prostate. 2017 Jun;77(8):859-865
pubmed: 28240424
Prostate. 2014 May;74(6):680-7
pubmed: 24481730
J Urol. 2010 Oct;184(4):1328-33
pubmed: 20723921
Pathology. 2020 Feb;52(2):192-196
pubmed: 31843189
Am J Surg Pathol. 2021 Aug 1;45(8):1118-1126
pubmed: 33999555
Mod Pathol. 2019 Jan;32(1):139-146
pubmed: 30349027
Am J Surg Pathol. 2015 Jan;39(1):67-74
pubmed: 25025445
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11428-11436
pubmed: 31061129
Hum Pathol. 2015 Aug;46(8):1204-8
pubmed: 26089205
Eur Urol. 2021 Feb;79(2):298-306
pubmed: 33279304
Arch Pathol Lab Med. 2015 Oct;139(10):1234-41
pubmed: 26414467
J Clin Oncol. 2014 Oct 20;32(30):3383-90
pubmed: 25225419
Histopathology. 2021 Jan;78(2):231-239
pubmed: 32692448
Br J Urol. 1998 Mar;81(3):413-8
pubmed: 9523662
Science. 2017 Jan 6;355(6320):84-88
pubmed: 28059768
Eur Urol. 2017 Nov;72(5):665-674
pubmed: 28511883
Mod Pathol. 2009 Mar;22(3):359-65
pubmed: 19151660
Int Urol Nephrol. 2013 Jun;45(3):735-42
pubmed: 23666549
Am J Surg Pathol. 2018 Aug;42(8):1036-1041
pubmed: 29878934
Eur J Cancer. 2021 Apr;147:74-83
pubmed: 33626496
Arch Pathol Lab Med. 2007 Jul;131(7):1122-5
pubmed: 17617002
Eur J Cancer. 2021 May;148:440-450
pubmed: 33678516
Am J Surg Pathol. 2003 Dec;27(12):1523-9
pubmed: 14657711
J Clin Oncol. 2020 Aug 20;38(24):2798-2811
pubmed: 32516092
Hum Pathol. 2015 Jun;46(6):805-12
pubmed: 25870120
Neoplasia. 2013 Jan;15(1):1-10
pubmed: 23358695
Am J Surg Pathol. 2016 Oct;40(10):1400-6
pubmed: 27379821
Am J Surg Pathol. 2016 Feb;40(2):244-52
pubmed: 26492179
Virchows Arch. 2021 Feb;478(2):249-256
pubmed: 32815034
Am J Surg Pathol. 2008 Jul;32(7):1060-7
pubmed: 18496142
Nat Med. 2016 Mar;22(3):298-305
pubmed: 26855148
Oncotarget. 2016 Dec 13;7(50):82504-82510
pubmed: 27756888
Mod Pathol. 2022 Aug;35(8):1092-1100
pubmed: 35145197
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2518-26
pubmed: 24966964
J Natl Compr Canc Netw. 2014 May;12(5):719-26
pubmed: 24812138
Arch Pathol Lab Med. 2021 Apr 1;145(4):461-493
pubmed: 32589068
Am J Cancer Res. 2021 Aug 15;11(8):3990-4001
pubmed: 34522463
Cancer. 2002 May 15;94(10):2610-7
pubmed: 12173328
Am J Surg Pathol. 2017 Apr;41(4):550-556
pubmed: 28009609
Am J Clin Pathol. 2010 Apr;133(4):654-61
pubmed: 20231619
JCO Precis Oncol. 2019;3:
pubmed: 31123724
Eur J Cancer. 2016 Oct;66:26-33
pubmed: 27522247
Eur Urol. 2020 Feb;77(2):191-198
pubmed: 31439369
Histopathology. 2016 Sep;69(3):441-9
pubmed: 27028587
Cancer. 1986 Jan 1;57(1):111-9
pubmed: 2416422
Science. 2018 Oct 5;362(6410):91-95
pubmed: 30287662
Virchows Arch. 2015 Oct;467(4):437-42
pubmed: 26229020
Prostate. 2019 Aug;79(11):1267-1273
pubmed: 31111513
Eur J Cancer. 2012 Jun;48(9):1318-25
pubmed: 22405699
Eur Urol. 2015 Mar;67(3):496-503
pubmed: 25154392
J Natl Compr Canc Netw. 2019 May 1;17(5):479-505
pubmed: 31085757
Prostate. 2019 Jul;79(10):1065-1070
pubmed: 31025722
Histopathology. 2017 Nov;71(5):693-702
pubmed: 28570007
Ann Diagn Pathol. 2019 Oct;42:48-58
pubmed: 31306859
Prostate. 2018 Apr;78(5):401-407
pubmed: 29368341
Histopathology. 2017 Feb;70(3):504-507
pubmed: 27614104
Mod Pathol. 2016 Jun;29(6):630-6
pubmed: 26939875
Hum Pathol. 2017 Jul;65:85-91
pubmed: 28504208
Eur J Cancer. 2014 Jun;50(9):1610-6
pubmed: 24703897
Am J Surg Pathol. 2016 Nov;40(11):1439-1456
pubmed: 27635949
J Clin Pathol. 2016 Oct;69(10):852-7
pubmed: 26926101
Cancer Cell. 2017 Oct 9;32(4):474-489.e6
pubmed: 29017058
Histopathology. 2019 Feb;74(3):474-482
pubmed: 30160779
Mol Cell. 2020 Nov 19;80(4):562-577
pubmed: 33217316
Adv Anat Pathol. 2021 Jul 1;28(4):276-287
pubmed: 33990497
Histopathology. 2013 Oct;63(4):574-9
pubmed: 23931616
Virchows Arch. 2016 Sep;469(3):313-9
pubmed: 27394432
Mod Pathol. 2021 Jan;34(1):184-193
pubmed: 32686748
Am J Surg Pathol. 2013 Dec;37(12):1855-61
pubmed: 24145642
Hum Pathol. 2010 Feb;41(2):281-5
pubmed: 20004936